Following the philosophy of "Precise Products, Predictable Effects, Health Protection", Kexing Biopharm is devoted to promoting the R&D of quality biopharmaceutical products with improved clinical value, acting as the safeguard of human's health.
Shenzhen Kexing Bioproducts Co., Ltd., was established as an industrial base for interferon production.
"Recombinant Human Interferon α1b for Injection" (SINOGEN) was officially approved for production as Class I biological products.
Shandong Kexing Bioproducts Co., Ltd. was established as an industrial platform for recombinant human erythropoietin.
"Recombinant Human Erythropoietin Injection (CHO Cell)" (EPOSINO) was officially approved for production as Class II biological products.
Recombinant Human Granulocyte Colony-stimulating Factor Injection (WHITE-C) was officially approved for production.
Combined Clostridium Butyricum and Bifidobacterium Powder/Capsule, Live (CHANG LEKANG) was officially approved for production.
The EPO agent not containing albumin obtained the certificate of invention patent (patent No. ZL200610146206.0).
We integrated the traditional Chinese medicine business focusing on KEHUANG CAPSULE around hepatopathy treatment.
Our technology center was ratified as the "Shandong Provincial Enterprise-level Technology Center"
Our technology center was ratified as the "Jinan Protein Therapeutics Engineering Laboratory".
We launched the slogan "Precise Products, Predictable Effects, Health Protection" and the new logo.
The company was restructured into Kexing Biopharmaceutical Co., Ltd. (Kexing Biopharm).